Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Evaluation of the Efficacy of Induction-consolidation Treatment Using a Double Induction in Patients With AML <60 Years Old
NCT02072811Phase 3Unknown
- Start
- Feb 2014
- Primary completion
- Feb 2018
- Modality
- Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of cladribine + cytarabine + granulocyte colony stimulating factor in acute myeloid leukemia (AML). Status: unknown.
02
Drugs
cladribine + cytarabine + granulocyte colony stimulating factor
03
Conditions
acute myeloid leukemia (AML)
Beyond the preview
Go deeper on NCT02072811.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02072811.